SIC 2834 – Pharmaceutical Preparations
| Valuation | |
|---|---|
| Market Cap ($M) | 11,178.17 |
| Enterprise Value ($M) | n/a |
| Book Value ($M) | 28,679.91 |
| Book Value / Share | 4.82 |
| Price / Book | n/a |
| NCAV ($M) | 24,463.86 |
| NCAV / Share | 4.11 |
| Price / NCAV | n/a |
| Profitability (mra) | |
|---|---|
| Return on Invested Capital (ROIC) | 0.15 |
| Return on Assets (ROA) | 0.14 |
| Return on Equity (ROE) | 0.16 |
| Liquidity (mrq) | |
|---|---|
| Quick Ratio | 9.94 |
| Current Ratio | 10.18 |
| Balance Sheet (mrq) ($M) | |
|---|---|
| Current Assets | 27,441.79 |
| Assets | 31,657.85 |
| Liabilities | 2,977.93 |
| Debt | n/a |
| Equity | n/a |
| Income Statement (mra) ($M) | |
|---|---|
| Revenue | 12,260.81 |
| Operating Income | 3,902.09 |
| Net Income | 4,371.82 |
| Cash Flow Statement (mra) ($M) | |
|---|---|
| Cash From Operations | 3,862.36 |
| Cash from Investing | -1,391.79 |
| Cash from Financing | -6,065.94 |
(click for more detail) |
|
| Top 13F Investors | Shares (1000) |
Change (%) |
Value ($1000) |
Change (%) |
|---|---|---|---|---|
(click for more detail) |
||||
| Date | Insider Trades | Code | Shares | Value |
|---|---|---|---|---|
(click for more detail) |
||||
| Similar Companies | |
|---|---|
| HENC – Hero Technologies Inc. | HJGP – Hanjiao Group, Inc. |
| HMDCF – HUTCHMED (China) Limited | HSTC – HST Global, Inc. |
| HSTOQ – Histogen Inc. |
Financial data and stock pages provided by
Fintel.io